- Home
- CLDI vs AHT Comparison
CLDI vs AHT Comparison
Compare CLDI & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- AHT
- Stock Information
- Founded
- CLDI 2014
- AHT 2003
- Country
- CLDI United States
- AHT United States
- Employees
- CLDI N/A
- AHT N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- AHT Real Estate Investment Trusts
- Sector
- CLDI Health Care
- AHT Real Estate
- Exchange
- CLDI Nasdaq
- AHT Nasdaq
- Market Cap
- CLDI 35.2M
- AHT 40.8M
- IPO Year
- CLDI N/A
- AHT 2003
- Fundamental
- Price
- CLDI $1.05
- AHT $8.50
- Analyst Decision
- CLDI Strong Buy
- AHT
- Analyst Count
- CLDI 3
- AHT 0
- Target Price
- CLDI $16.67
- AHT N/A
- AVG Volume (30 Days)
- CLDI 2.7M
- AHT 39.7K
- Earning Date
- CLDI 03-14-2025
- AHT 02-25-2025
- Dividend Yield
- CLDI N/A
- AHT N/A
- EPS Growth
- CLDI N/A
- AHT N/A
- EPS
- CLDI N/A
- AHT 1.83
- Revenue
- CLDI N/A
- AHT $1,215,615,000.00
- Revenue This Year
- CLDI N/A
- AHT N/A
- Revenue Next Year
- CLDI N/A
- AHT N/A
- P/E Ratio
- CLDI N/A
- AHT $4.65
- Revenue Growth
- CLDI N/A
- AHT N/A
- 52 Week Low
- CLDI $0.58
- AHT $5.20
- 52 Week High
- CLDI $16.80
- AHT $20.80
- Technical
- Relative Strength Index (RSI)
- CLDI 45.04
- AHT 52.80
- Support Level
- CLDI $1.16
- AHT $8.64
- Resistance Level
- CLDI $1.30
- AHT $9.30
- Average True Range (ATR)
- CLDI 0.24
- AHT 0.68
- MACD
- CLDI 0.01
- AHT 0.10
- Stochastic Oscillator
- CLDI 40.10
- AHT 43.77
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
About AHT Ashford Hospitality Trust Inc
Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides rest estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.